Skip to main content

Blogs

Behind the Bill
09/04/2024
This is a continuation of our Behind the Bill on the FDA’s new guidance for biosimilar interchangeability.
This is a continuation of our Behind the Bill on the FDA’s new guidance for biosimilar interchangeability.
This is a continuation of our...
09/04/2024
First Report Managed Care
Behind the Bill
08/28/2024
FDA eases biosimilar interchangeability rules, dropping switching studies. New guidance and legislation aim to boost access and lower costs.
FDA eases biosimilar interchangeability rules, dropping switching studies. New guidance and legislation aim to boost access and lower costs.
FDA eases biosimilar...
08/28/2024
First Report Managed Care
Blog
07/29/2024
The Centers for Medicare and Medicaid Services recently released final part two guidance on the Medicare Prescription Payment Plan (M3P), formerly known as "smoothing."
The Centers for Medicare and Medicaid Services recently released final part two guidance on the Medicare Prescription Payment Plan (M3P), formerly known as "smoothing."
The Centers for Medicare and...
07/29/2024
First Report Managed Care
Blog
07/18/2024
Learn why industry stakeholders should prepare for 2028 negotiations now to ensure long-term financial stability and regulatory compliance.
Learn why industry stakeholders should prepare for 2028 negotiations now to ensure long-term financial stability and regulatory compliance.
Learn why industry stakeholders...
07/18/2024
First Report Managed Care
Blog
07/11/2024
The IRA has spawned a series of lawsuits from pharmaceutical companies. Here, we provide the latest status updates on several of them.
The IRA has spawned a series of lawsuits from pharmaceutical companies. Here, we provide the latest status updates on several of them.
The IRA has spawned a series of...
07/11/2024
First Report Managed Care
Blog
07/09/2024
In this blog the HMP Market Access Intelligence team breaks down the knowns and unknowns of the Inflation Reduction Act's impact on drug price negotiations and what the future may hold.
In this blog the HMP Market Access Intelligence team breaks down the knowns and unknowns of the Inflation Reduction Act's impact on drug price negotiations and what the future may hold.
In this blog the HMP Market...
07/09/2024
First Report Managed Care